Table 3 Sensitivity of TP according to disease location and severity
Participants with Diabetes (N = 176) | Control Group (N = 218) | |||
|---|---|---|---|---|
PAD anatomical distribution | N | TP sensitivity (95%CI) | N | TP sensitivity (95%CI) |
Proximal disease | 18 | 77.78 (52.36 to 93.59) | 33 | 69.70 (51.20 to 84.41) |
Distal disease | 61 | 68.85 (55.71 to 80.10) | 82 | 61.73 (50.26 to 72.31) |
Both proximal and distal disease | 39 | 79.49 (63.54 to 90.70) | 46 | 82.61 (68.58 to 92.18) |
PAD severity | N | TP sensitivity (95%CI) | N | TP sensitivity (95%CI) |
>50% - 75% | 11 | 81.82 (48.22 to 97.72) | 18 | 50.00 (26.02 to 73.98) |
>75% | 11 | 45.45 (16.75 to 76.62) | 26 | 80.77 (60.65 to 93.45) |
Occlusion | 96 | 76.04 (66.25 to 84.17) | 117 | 70.94 (61.83 to 78.96) |